Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease

医学 恶化 慢性阻塞性肺疾病急性加重期 急诊医学 气道正压 梅德林 机械通风 随机对照试验 呼吸衰竭 重症监护医学 内科学 政治学 法学 阻塞性睡眠呼吸暂停
作者
Christian Robert Osadnik,Vanessa Tee,Kristin Carson‐Chahhoud,Joanna Picot,Jadwiga Anna Wedzicha,Brian James Smith
出处
期刊:The Cochrane library [Wiley]
卷期号:2017 (7): CD004104-CD004104 被引量:422
标识
DOI:10.1002/14651858.cd004104.pub4
摘要

BACKGROUND: Non-invasive ventilation (NIV) with bi-level positive airway pressure (BiPAP) is commonly used to treat patients admitted to hospital with acute hypercapnic respiratory failure (AHRF) secondary to an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). OBJECTIVES: To compare the efficacy of NIV applied in conjunction with usual care versus usual care involving no mechanical ventilation alone in adults with AHRF due to AECOPD. The aim of this review is to update the evidence base with the goals of supporting clinical practice and providing recommendations for future evaluation and research. SEARCH METHODS: We identified trials from the Cochrane Airways Group Specialised Register of trials (CAGR), which is derived from systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Allied and Complementary Medicine Database (AMED), and PsycINFO, and through handsearching of respiratory journals and meeting abstracts. This update to the original review incorporates the results of database searches up to January 2017. SELECTION CRITERIA: ) > 45 mmHg (6 kPa). Primary review outcomes were mortality during hospital admission and need for endotracheal intubation. Secondary outcomes included hospital length of stay, treatment intolerance, complications, changes in symptoms, and changes in arterial blood gases. DATA COLLECTION AND ANALYSIS: Two review authors independently applied the selection criteria to determine study eligibility, performed data extraction, and determined risk of bias in accordance with Cochrane guidelines. Review authors undertook meta-analysis for data that were both clinically and statistically homogenous, and analysed data as both one overall pooled sample and according to two predefined subgroups related to exacerbation severity (admission pH between 7.35 and 7.30 vs below 7.30) and NIV treatment setting (intensive care unit-based vs ward-based). We reported results for mortality, need for endotracheal intubation, and hospital length of stay in a 'Summary of findings' table and rated their quality in accordance with GRADE criteria. MAIN RESULTS: . Treatment intolerance was significantly greater in the NIV group than in the usual care group (risk difference (RD) 0.11, 95% CI 0.04 to 0.17; N = 6 studies). Results of analysis showed a non-significant trend towards reduction in dyspnoea with NIV compared with usual care (standardised mean difference (SMD) -0.16, 95% CI -0.34 to 0.02; N = 4 studies). Subgroup analyses revealed no significant between-group differences. AUTHORS' CONCLUSIONS: Data from good quality randomised controlled trials show that NIV is beneficial as a first-line intervention in conjunction with usual care for reducing the likelihood of mortality and endotracheal intubation in patients admitted with acute hypercapnic respiratory failure secondary to an acute exacerbation of chronic obstructive pulmonary disease (COPD). The magnitude of benefit for these outcomes appears similar for patients with acidosis of a mild (pH 7.30 to 7.35) versus a more severe nature (pH < 7.30), and when NIV is applied within the intensive care unit (ICU) or ward setting.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ouoii3完成签到,获得积分10
刚刚
正直无极完成签到,获得积分10
2秒前
heeh发布了新的文献求助10
3秒前
乐鱼发布了新的文献求助10
3秒前
张莹发布了新的文献求助30
3秒前
3秒前
double_manager的应助被Gxt采纳,获得10
3秒前
zyy发布了新的文献求助10
4秒前
4秒前
zan12131发布了新的文献求助30
4秒前
义气傲薇发布了新的文献求助10
5秒前
6秒前
6秒前
helping完成签到 ,获得积分10
6秒前
苏邑发布了新的文献求助10
6秒前
长风赴宴完成签到 ,获得积分10
6秒前
6秒前
6秒前
甜蜜发带完成签到 ,获得积分0
6秒前
7秒前
11完成签到,获得积分10
7秒前
酷炫师发布了新的文献求助10
7秒前
7秒前
Lucas的应助被Humingyu采纳,获得10
7秒前
9秒前
9秒前
Nia发布了新的文献求助10
9秒前
简单山水发布了新的文献求助10
9秒前
小孙大王发布了新的文献求助10
10秒前
10秒前
10秒前
踏实初蓝完成签到,获得积分20
10秒前
科研岗完成签到,获得积分10
10秒前
11秒前
唐唐发布了新的文献求助10
11秒前
xhy完成签到 ,获得积分10
11秒前
ini发布了新的文献求助10
11秒前
yan完成签到,获得积分10
11秒前
风_Feng完成签到,获得积分10
12秒前
流沙发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181379
求助须知:如何正确求助?哪些是违规求助? 9571317
关于积分的说明 21817457
捐赠科研通 7777820
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479523